Clinical trial
Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical…
NCT00225667 · Connolly, Stuart, M.D., Other · Unknown status
Key facts
| NCT number | NCT00225667 |
|---|---|
| Title | Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers |
| Official title | Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension, Permanent Pacemakers and Risk Factors for Developing Atrial Fibrillation |
| Lead sponsor | Connolly, Stuart, M.D., Other |
| Collaborators | Sanofi Industry Bristol-Myers Squibb |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation, Hypertension |
| Intervention type | Drug |
| Interventions | Irbesartan |
| Enrollment | 200 |
| Start date | Dec 1, 2005 |
| Completion | Jul 1, 2007 |
| First posted | Sep 26, 2005 |
| Last update posted | Nov 23, 2005 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: